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Abstract: Interference with zinc absorption is a proposed explanation for adverse effects of 
supplemental iron in iron-replete children in malaria endemic settings. We examined the 
effects of iron in micronutrient powder (MNP) on zinc absorption after three months of home 
fortification with MNP in maize-based diets in rural Kenyan infants. In a double blind 
design, six-month-old, non-anemic infants were randomized to MNP containing 5 mg zinc, 
with or without 12.5 mg of iron (MNP + Fe and MNP − Fe, respectively); a control (C) group 
received placebo powder. After three months, duplicate diet collections and zinc stable 
isotopes were used to measure intake from MNP + non-breast milk foods and fractional 
absorption of zinc (FAZ) by dual isotope ratio method; total absorbed zinc (TAZ, mg/day) 
was calculated from intake × FAZ. Mean (SEM) TAZ was not different between MNP + Fe 
(n = 10) and MNP − Fe (n = 9) groups: 0.85 (0.22) and 0.72 (0.19), respectively, but both 
were higher than C (n = 9): 0.24 (0.03) (p = 0.04). Iron in MNP did not significantly alter 
zinc absorption, but despite intakes over double estimated dietary requirement, both MNP 
groups’ mean TAZ barely approximated the physiologic requirement for age. Impaired zinc 
absorption may dictate need for higher zinc doses in vulnerable populations. 
OPEN ACCESS 
Nutrients 2014, 6 5637 
 
 
Keywords: zinc absorption; micronutrient powders; iron supplementation; malaria; Kenya 
 
1. Introduction 
Iron deficiency and iron deficiency anemia are among the most prevalent and intractable public health 
problems in infants and young children, particularly in malaria-endemic, resource-limited settings. 
However, oral iron supplementation has been associated with increased mortality and rates of adverse 
events from infectious diseases in older iron-replete infants and toddlers in a malaria endemic area [1]. 
These adverse outcomes have prompted critical re-evaluation of approaches to prevent iron deficiency 
and iron deficiency anemia [2,3]. There is an urgent need to identify the mechanisms of such untoward 
effects of iron administration, since halting population-based initiatives in the face of widespread 
deficiency is not an option. 
Interference with zinc absorption and/or metabolism is one proposed explanation for the adverse 
effects of iron supplements in iron replete subjects in malaria endemic areas [2]. Evidence for an 
interaction between iron and zinc is conflicting [4,5], and actual mechanisms are not clear. Iron 
supplements have been associated with a reduction in plasma zinc concentrations [6–8]. In two studies of 
lactating women, iron supplementation was associated with lower fractional absorption of zinc [9,10]. 
Studies in pregnant women have reported conflicting results for an effect of iron supplements on zinc 
absorption [11,12]. Neither iron added to food through fortification, nor supplemental iron when ingested 
with meals has been found to have an adverse effect on zinc absorption in healthy subjects [13,14]. A 
recently published mathematical model of zinc absorption in adults found no effect of iron on zinc 
absorption when calcium and protein intakes were controlled for [15]. Studies examining this issue in 
young children in low resource settings, however, are limited. 
For this study, we examined in a vulnerable population the effects on zinc absorption of increased 
iron intake by comparing micronutrient powder (MNP) with and without iron, compared to a study group 
receiving placebo MNP as a control. The setting for the study was rural Kenya, where iron deficiency is 
high in older infants and toddlers; local diets for complementary feeding are typically monotonous, plant 
based foods low in iron and zinc and high in phytate; and malaria is endemic. 
The objective was to determine the effects of iron in MNP on zinc absorption and the size of the 
exchangeable zinc pool (EZP), as an indicator of zinc status, after three months of home fortification 
with MNP in maize-based diets. We hypothesized that there would be a significantly lower absorption 
of zinc in the MNP with iron compared to that of the infants receiving MNP without iron. 
2. Experimental Section 
2.1. Study Design 
The study was a randomized, double blinded comparison of total daily zinc absorption in 15 infants 
(9 months of age) from each of three MNP groups: one with multiple micronutrients, including 5 mg 
zinc and 12.5 mg iron (MNP + Fe); another with same composition except no iron (MNP − Fe); and 
control with placebo sachets including no micronutrients (C). The daily MNP intervention was started 
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at 6 months of age, when all subjects were predominantly breastfed (no formula). All meals for a day 
were extrinsically labeled with one of two stable isotopes of zinc; 67Zn was administered with the meal 
containing the MNP sachet, and 70Zn was used to label other meals of the day. An intravenous dose of a 
third stable isotope of zinc (68Zn) was administered to enable measurement of zinc absorption by dual 
isotope tracer ratio (DITR) in urine method [16]. In conjunction with the intravenous isotope 
administration, blood was drawn for biomarkers of iron and zinc status. The size of the EZP was also 
determined from the enrichment of 68Zn in urine [17]. 
2.2. Study Setting 
The study was undertaken in rural western Kenya, approximately 150 km from Moi University 
Medical School in Eldoret. The villages are characterized by extreme poverty, with 40%–80% of the 
population living below the World Bank defined poverty level. The predominant occupation is 
subsistence farming. Most families live in traditional homes with mud walls, dirt floors, thatched roofs; 
virtually none had in-home electricity or public water source. The area is holoendemic for P. falciparum 
malaria. The traditional diets are monotonous, predominantly maize-based. For the infants participating 
in the study, the diets were primarily maize-based porridge mixed with breast milk; diets also included 
some ugali (maize), vegetables, and occasional meat soups. 
A convenience sample of 45 infants was drawn from participants in the Maternal and Neonatal 
Registry study of the Global Network for Women’s and Children’s Health [18]. Families who had 
successfully participated in the registry were approached for participation in the MNP supplementation 
and zinc absorption study when the infants were approximately 5 months old. The registry administrators 
of this cluster were requested to provide a list of 45 consecutive infants at this age from their registers 
for inclusion into the study based on the study inclusion criteria. Infants drawn from only two of the  
39 villages in the cluster were selected for ease of follow up. The infants’ homes were visited by the 
study field staff accompanied by the registry administrator for purposes of identification. 
2.3. Subjects 
Subjects were enrolled just prior to 6 months of age and received the randomly assigned daily  
MNP until 9 months of age. Inclusion criteria included the infant having been born at term with birth 
weight > 2500 g; healthy appearance with no apparent congenital anomalies; current immunization status; 
family social situation such that they were able to comply with study requirements; willingness to 
provide informed consent and agree to weekly visits for MNP distribution and data collection, as well 
as stool, urine and blood collections; hemoglobin concentration ≥ 10 g/dL; infant still breastfeeding at 
enrollment and intended to continue during the three months of the study period; and negative blood 
slide for malaria parasites. Exclusion criteria included existing acute malnutrition, especially wasting, 
with weight for length ≤ 2 SD by World Health Organization (WHO) infant growth standards; current 
or planned use of infant formula or other nutrient fortified products; current or planned use of iron or 
zinc supplements; anemia (defined as Hb < 10 g/dL); previous hospitalization for malaria within the last 
four weeks; and persistent diarrhea (per WHO, >3 loose stools/day lasting ≥14 days). Infants’ stools 
were screened for helminthes; none were positive for infestation. Approval from the institutional and 
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ethics review committees at Moi University School of Medicine and the University of Colorado was 
obtained prior to study implementation. The study is registered in ClinicalTrials.gov NCT02101723. 
Sample size calculations were based on results of infant zinc absorption studies previously conducted 
in the University of Colorado Denver (UCD) laboratory [19,20]. With the use of independent sample  
t-tests, we used PASS software (NCSS—Number Cruncher Statistical Systems 2007 and PASS 2008; 
Number Cruncher Statistical Systems, Kaysville, UT, USA) to estimate that we would have 82%–93% 
power (depending on absolute amounts of absorbed zinc) to detect a difference of 0.2 mg of daily 
absorbed zinc between the 3 complementary food groups with 15 subjects per group. This amount of 
absorbed zinc represents approximately 25% of the estimated physiologic requirement for zinc at  
this age. 
2.4. Randomization and Enrollment 
Potential families were visited and educated on the proposed study before the enrollment visit and the 
study nurse or lab technologist obtained written informed consent from the parents/guardians plus 
witness upon confirmation that the child met the inclusion and exclusion criteria. Forty-five pieces of 
paper with letters marked A, B or C to represent the three study arms were rolled into balls and placed 
in a plastic container. The pieces were mixed thoroughly through shaking of the container. An 
independent person then picked the pieces one by one from the container. The unique number-letter 
became the subject and group assignment for each individual. 
2.5. Intervention 
The micronutrient content of the two MNP preparations included zinc (5 mg), Vitamin A (300 μg), 
Vitamin C (30 mg), folic acid (160 μg), and iron (12.5 mg or 0 mg). The powder for Group C was a 
product very similar to the other group powders without the additional micronutrients. All of the MNP 
sachets were marked with either A, B, or C by the manufacturer (Hexagon Nutrition Pvt. Ltd., Mumbai, 
India), and were otherwise indistinguishable. The code was known only to a senior investigator not 
involved in the field work (FE), thus assuring blinding of group assignment to the participating subjects 
and to the field research teams. Laboratory analysis at the University of Colorado verified the accuracy 
of the zinc and iron contents of the products. 
The MNP were provided at weekly intervals during the 3-month intervention period from  
6–9 months of age. At the end of each visit 7 sachets were left with the mother plus 3 extra in case a 
delay occurred in follow up visits. Mothers were instructed to give one sachet daily and to add the entire 
contents of the sachet to one meal. All children were followed up once a week by the nurse or clinical 
officer to ascertain if the MNP were taken during the 3 months of follow up and to replenish the next 
week’s supply of the MNP sachets. 
2.6. Anthropometry 
For descriptive purposes, length and weight were obtained on the infants at enrollment and at the end 
of the study period. Lengths were measured with a portable infantometer supplied by the Ministry of 
Health, Department of Nutrition; instrument was accurate to 0.5 cm. Weights were obtained with a 
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weighing scale model RGZ-20 (Wuxi Weight Factory, Wuxi City, China), accurate to 50 g. The field 
team received extensive training prior to the initiation of the field studies. Measurements were taken in 
triplicate at the village elders’ homes where the infantometer and scale were maintained [21]. 
2.7. Zinc Absorption Study 
The isotope studies were undertaken when the participating infants were approximately 9 months of 
age. Baseline stool and urine specimens were taken prior to isotope dosing. Weighed doses of oral stable 
isotope 67Zn were administered on day 1 with the MNP meal (primarily ugali maize porridge). Weighed 
doses of 70Zn were administered with all other meals (excluding breast milk). For both isotopes, the 
doses were based on the estimated amount of zinc in the meals (non-MNP and MNP), with the total dose 
representing approximately 10% of daily zinc intake (estimated to be ~6–7 mg/day for the MNP groups 
and 1–2 mg/day for the control group). Thus, the isotope doses were the same for the two MNP groups 
containing zinc and lower for the placebo MNP preparation. The isotope preparations were 
indistinguishable except for labeling, to maintain the blinding of the MNP group assignment. After the 
last meal of the day, the dose of 68Zn was administered intravenously into an antecubital vein. Infusion 
of the isotope dose was followed by infusion of 2 rinses of normal saline to assure administration of the 
complete dose. Extensive training and supervision of the isotope administration and specimen collections 
were provided by the UCD team (Diana Culbertson, Nancy F. Krebs and K. Michael Hambidge). A manual 
of operations was developed for all procedures and availed to field personnel. All supplies for the isotope 
studies were metal-free and provided by the UCD team.  
2.7.1. Isotope Dose Preparation and Administration 
Enriched stable isotopes of zinc were obtained from Trace Science International (Richmond Hill, 
Canada). Accurately weighed quantities of each isotopically enriched preparation were dissolved in 0.5 
mol/L H2SO4 and then diluted with deionized water to prepare stock solutions. To prepare the oral doses, 
the stock solutions of 70Zn (95.5% enrichment) and 67Zn (94.2% enrichment) were diluted with purified 
water and titrated to a pH 3.0 with metal-free ammonium hydroxide. Zinc concentrations of the solutions 
were determined by triplicate measure of the preparation using atomic absorption spectrophotometry, 
adjusting the concentration measurements for the different atomic weights of the preparations. To 
prepare the intravenous dose, a stock solution of 68Zn (99.4% enrichment) was diluted with 0.45% saline, 
adjusted to pH 6.0 and then filtered through a 0.22-μm filter to ensure sterility. The pharmaceutical 
quality of the sterile solution (i.e., sterility and pyrogenicity) was certified by the University of Colorado 
Hospital pharmacy and the core laboratory of the General Clinical Research Center, respectively. 
Solutions of the 70Zn and 67Zn were given as small sips, starting at the mid-point of each meal, 
alternating between bites of the foods and the labeled solution. All losses of doses from drooling or spits 
were collected on ashless filter paper during the dose administration. These were analyzed using  
ICP-MS (inductively coupled plasma mass spectrometry) and the amount of isotope lost during 
administration was subtracted from the calculated dose to give a final administered isotope dose. 
Intravenous infusion of 68Zn was undertaken through a “butterfly” needle and tubing; a 3-way  
stop-cock was used to allow infusion through one port and rinsing of isotope syringe through the other 
port. Prior to infusion of the isotope dose, blood for the ancillary biomarkers was obtained. 
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2.7.2. Sample Collections 
Weighed duplicate diets were collected for the entire day of the isotope studies and transferred to 
polypropylene containers. Approximately 20 mL urine samples were collected twice a day (a.m. and 
p.m.) for days 4 to 7 after the oral isotope administration. Urine was collected using standard zinc-free 
pediatric urine collection bags, and subsequently transferred to clean polypropylene containers. Diet and 
urine specimens were frozen at −20 °C until shipment to UCD. 
2.7.3. Sample Processing and Analysis 
Duplicate diets were dried in an electric drying oven before ashing at 450 °C; samples were 
reconstituted in 6 M HCl and total zinc concentration was measured using atomic absorption 
spectrophotometry fitted with a deuterium arc background lamp (model AAnalyst 400, Perkin-Elmer 
Corporation, Norwalk, CT, USA) [22]. Urine samples were digested using a MARS microwave sample 
preparation system (CEM Corp, Matthews, NC, USA), as previously described [22]. Isotope enrichment 
was determined by measurement of the isotope ratios 67Zn/66Zn, 68Zn/66Zn and 70Zn/66Zn by inductively 
coupled plasma mass spectrometry (Agilent 7700x ICP-MS, Agilent Technologies, Santa Clara, CA, 
USA) and conversion of ratios to enrichment using a mathematical matrix. Tracer enrichment was 
defined as all of the zinc in the sample that was derived from the isotopically enriched tracer preparation 
divided by the total zinc in the sample [23]. 
2.8. Biomarkers  
Blood was obtained at 6 and 9 months for serum zinc, biomarkers of iron status (ferritin and soluble 
transferrin receptor (sTfR)), and systemic inflammatory markers α 1-acid glycoprotein (AGP) and  
C-reactive protein (CRP). A portable field based hemoglobin analyzer (HemoCue 201+, HemoCue 
America, Brea, CA, USA) was used for screening hemoglobin measurements, and a Partec Malaria 
Cyscope machine (Partec East Africa Ltd., Nairobi, Kenya) was used for malaria screening. Blood was 
centrifuged at the homestead using a handheld centrifuge (Hettich Hand-zentrifuge 1011, Tuttlingen, 
Germany). Syringes and storage tubes were all zinc free, and precautions were taken in the field to avoid 
zinc contamination. The specimens were placed on ice at the home visits, and were held in a −20 °C 
freezer for overnight stay at the local hospital until transport to the −70 °C freezer at Moi University the 
next day using an ice packed vaccine carrier. Serum zinc was analyzed by atomic absorption 
spectrophotometry with background correction, and AGP by R & D Systems Quantikine Enzyme-linked 
Immunosorbant Assay (ELISA); both were run in the Pediatric Nutrition Laboratory at UCD. Serum 
ferritin, sTfR, and CRP were analyzed by nephelometry in the Pediatric Clinical Translational Research 
Center core laboratory at UCD. 
2.9. Data Processing and Statistical Analyses 
2.9.1. Data Processing 
Paper data forms were developed for all activities and biospecimen collections. Data entry was 
conducted in Eldoret into a secure, web-based data management system (REDCap, Research Electronic 
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Data Capture, supported by the Colorado Clinical Translational Science Institute at UCD), and was 
accessible to only registered research team members at UCD, Indiana University and Moi University.  
The total daily dietary intake of zinc from all non-breast milk foods at the time of the metabolic 
studies was determined from the zinc content in the duplicate diet. Fractional absorption of zinc (FAZ) 
was measured by the DITR in urine method [16]. Specifically, FAZ = enrichment (oral/intravenous) × 
dose (intravenous/oral). Daily “total” absorbed zinc (TAZ, mg/day) from all non-breast milk foods was 
calculated by multiplying daily dietary zinc intake (mg) by FAZ. The EZP, defined as the estimate  
of the total size of the combined pools of zinc that exchange with zinc in plasma within approximately 
2–3 days, was calculated by dividing the dose of intravenous isotope (68Zn) infused by the enrichment 
value at the y-intercept of the linear regression of a semi-log plot of urine enrichment data from study 
days 5–8 after isotope administration [17]. 
2.9.2. Statistical Analyses 
Results were analyzed and plots created using GraphPad Prism version 6 (GraphPad Software,  
San Diego, CA, USA). The R statistical programming environment was also used for statistical  
analysis [24]. Group data sets were examined for normality and homoscedasticity. To minimize the 
impact of outliers and skewed distributions, 12.5% trimmed means were used in the equality of means 
testing of the zinc isotope data. One-way ANOVA and Tukey’s honest significant difference (HSD) 
multiple comparisons test were used when data were normally distributed and exhibited equal variances. 
When variances were not equal, Welch’s F test and the Dunnett-Tukey-Krammer multiple comparisons 
test were used to compare means. Repeated measure ANOVA was used to assess the effect of time and 
group for growth and biochemical assays. Data are presented as mean (SEM) unless otherwise noted. 
Significance was defined at α = 0.05 level. 
3. Results 
No differences in demographic or anthropometric measurements were observed among the study 
groups at either baseline or end of the intervention. Weight and length both significantly increased over 
the study period (Table 1). No cases of malaria were identified in the subjects during the study period. 
Compliance monitoring for the assigned MNP indicated >90% consumption among all of the participants. 
Isotope studies were successfully completed on 10, 8, and 9 subjects in the MNP + Fe, MNP − Fe, 
and Control groups, respectively. Reasons for failure to complete the isotope studies included participant 
withdrawal from the study during the intervention stage (n = 7) or technical difficulties with isotope 
administration and/or incomplete sample collections (n = 11) (Figure 1). 
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Table1. Demographic and anthropometric data at 6 and 9 months 1. 
 6 months of Age 9 months of Age 
 
MNP + Fe  
(n = 15) 
MNP − Fe  
(n = 15) 
Control  
(n = 15) 
MNP + Fe  
(n = 10) 
MNP − Fe  
(n = 8) 
Control  
(n = 9) 
Gender       
Male 5 (33%) 7 (47%) 10 (67%) 3 (30%) 3 (37%) 7 (78%) 
Female 10 (67%) 8 (53%) 5 (33%) 7 (70%) 5 (63%) 2 (22%) 
Weight, kg 2 7.25 (0.25) 7.55 (0.27) 7.49 (0.22) 8.17 (0.32) 8.2 (0.44) 8.37 (0.36) 
WAZ 3 −0.39 (0.25) −0.16 (0.31) −0.21 (0.25) −0.36 (0.32) −0.33 (0.45) −0.38 (0.41) 
Length, cm 2 65.0 (0.7) 66.5 (0.9) 64.6 (0.8) 67.9 (1.2) 70.2 (1.7) 69.5 (2.0) 
LAZ 3 −0.68 (0.27) −0.19 (0.40) −1.01 (0.39) −1.16 (0.39) −0.21 (0.83) −0.71 (0.86) 
1 Mean (SEM); 2 repeated measure ANOVA showed no difference between groups at 6 months or 9 months, 
significant increase over time for both weight (p < 0.01) and length (p < 0.05) without group effect; 3 repeated 
measure ANOVA showed no difference between groups at 6 months or 9 months, no significant effect of time 
or group. MNP, micronutrient powder; WAZ, weight-for-age Z-score; LAZ, length-for-age Z-score. 
Figure 1. Consort diagram. MNP, micronutrient powder. 
 
Equality tests of the trimmed means of daily zinc intake, FAZ, TAZ, and EZP all indicated significant 
differences. As expected, the MNP provided a large increase in daily zinc intake over that consumed 
from the usual diets, represented by the C group. Due to the large difference in variance between the 
control and intervention groups, the Welch test was used to compare the zinc intake means, resulting in 
p < 0.0001. One-way ANOVA detected significant differences in the mean FAZ and TAZ (Welch test) 
from the MNP meals and in EZP. For intake, FAZ, TAZ, and EZP, the post-tests on the trimmed data 
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showed that the MNP + Fe and MNP − Fe groups were not different and that the control group was 
different from either intervention group (Figure 2). 
Data from the zinc absorption studies in all subjects are summarized in Table 2. 
Figure 2. Box and whisker plots of trimmed mean data for (A) fractional absorption of Zinc 
(FAZ) from micronutrient powder (MNP) meals; (B) total absorbed zinc (TAZ) from MNP 
meals and (C) exchangeable zinc pool (EZP) after 3 months on intervention. “+” indicates 
mean value. Different superscripts denote significant differences between groups (ANOVA). 
 
Table 2. Untrimmed data for zinc intake from complementary foods with and without 
micronutrient powder (MNP) added to the meal, fractional absorption, and total absorbed 
zinc by group 1. 
 
MNP + Fe  
(n = 10) 
MNP − Fe  
(n = 8) 
Control  
(n = 9) 
p-value  
(ANOVA) 
Total Daily Zn Intake, mg/day 6.53 (0.22) a 6.69 (0.28) a 0.90 (0.11) b 0.0001 
FAZ, non-MNP meals 0.22 (0.04) 0.20 (0.04) 0.27 (0.01) 0.41 
FAZ, MNP meals 0.12 (0.04) a 0.09 (0.03) a 0.25 (0.04) b 0.01 
TAZ 2, mg/day 0.85 (0.22) a 0.72 (0.19) ab 0.24 (0.03) b 0.04 
1 Mean (SEM) different superscripts within a row denote significant differences (p < 0.05); 2 sum of absorbed 
zinc from non-MNP meals +MNP meals. FAZ, fractional absorption of Zinc; TAZ, total absorbed zinc. 
Results of hemoglobin, serum zinc and EZP, and inflammatory markers for each group at the 
beginning and end of the study are presented in Table 3. No difference was observed by group or time 
for any of the iron biomarkers except sTfR, which showed a significant increase over time (p = 0.02) 
and a trend of group-by-time interaction (p = 0.09) for the increase that occurred in the placebo and the 
MNP − Fe group. Means for CRP were above the upper limit of the normal range for all groups at both 
time points. In addition, plasma Zn concentration significantly decreased over time (p = 0.008) without 
any group effect. Mean EZP of all data, measured after three months on intervention, did not differ  
by group. 
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Table 3. Biomarkers at 6 and 9 months 1.  
Biomarker MNP + Fe MNP − Fe Control 
Hemoglobin, g/dL 
6 months 11.3 ± 0.8 (10) 12.4 ± 1.0 (8) 12.0 ± 0.5 (9) 
9 months 12.0 ± 0.4 (10) 14.3 ± 0.9 (4) 12.8 ± 0.5 (8) 
Plasma Zn, μg/dL 2 (60–110) 
6 months 80.8 ± 1.0 (8) 78.3 ± 7.1 (6) 81.1 ± 6.4 (9) 
9 months 70.2 ± 5.6 (8) 69.8 ± 5.4 (6) 62.2 ± 4.2 (9) 
Ferritin, μg/L (17–145) 
6 months 46.9 ± 9.8 (8) 25.4 ± 6.7 (6) 38.7 ± 6.7 (9) 
9 months 49.9 ± 12.7 (8) 26.5 ± 10.9 (6) 23.7 ± 11.1 (9) 
Serum transferrin receptor (sTfR), mg/L 3 (0.76–1.76) 
6 months 3.0 ± 0.4 (10) 2.4 ± 0.2 (8) 2.8 ± 0.1 (9) 
9 months 2.8 ± 0.3 (10) 3.1 ± 0.4 (8) 4.0 ± 0.4 (8) 
Α 1-acid glycoprotein (AGP), mg/dL (50–120) 
6 months 87.4 ± 14.1 (10) 81.0 ± 17.3 (7) 81.6 ± 14.5 (9) 
9 months 90.9 ± 19.3 (10) 80.8 ± 11.5 (7) 79.7 ± 12.9 (9) 
C-reactive protein (CRP), mg/L (<3) 
6 months 7.7 ± 4.5 (10) 11.5 ± 5.9 (8) 5.3 ± 1.8 (8) 
9 months 6.2 ± 3.4 (10) 8.3 ± 4.2 (8) 6.2 ± 1.7 (9) 
Exchangeable zinc pool (EZP), mg/kg 
9 months 3.7 (0.4) 4.0 (0.4) 3.0 (0.6) 
1 Mean ± SEM (n), repeated measure ANOVA was used to assess the effect of group and time  
(6 months vs. 9 months), normal range in parentheses follows biomarker heading; 2 effect of time (p = 0.008): 
plasma Zn concentration decreased over time without differences between groups; 3 effect of time (p = 0.02): 
sTfR increased over time; A trend of time-by-group interaction was observed (p = 0.09): sTfR increased in  
MNP − Fe and Control groups but not in MNP + Fe group. MNP, micronutrient powder.  
4. Discussion 
The results of this study do not support an adverse effect of the fortificant iron from MNP on zinc 
absorption in this group of infants in a malaria endemic area. This is consistent with others’ conclusions 
that iron fortification of a meal does not adversely affect zinc absorption [13,14,25]. An additional 
important finding, however, is the lower than expected zinc absorption, regardless of iron content of the 
MNP fortified meals. 
Despite a substantially increased zinc intake compared to usual intakes for this community 
(represented by the placebo group) and relative to the EAR of 2.5 mg/day for this age, the amount of 
daily absorbed zinc (TAZ) was at or below the estimated physiologic requirement of 0.84 mg/day [26]. 
Similar fractional absorption from maize-based test meals (without an extended MNP intervention) was 
reported by Zlotkin et al. for infants in Ghana who received MNP containing 30 mg of iron and either  
5 or 10 mg of zinc. In that study infants, only the high zinc preparation resulted in absorbed zinc at the 
estimated physiologic requirement, whereas the mean absorption from the 5 mg preparation was only 
0.3 mg, even less than observed in the current study [27]. By comparison, nine-month-old breastfed 
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infants in Denver achieved daily absorbed zinc near the physiologic requirement from complementary 
foods with average zinc intakes that averaged only about 60% of the intakes for the Kenyan infants 
receiving the zinc containing MNP [22]. The conclusion that the absorption of zinc was impaired in the 
present study is also supported by examination of the data from other groups of young children in low 
resource settings, for whom the amount of absorbed zinc was similar to that achieved in the current study 
despite lower dietary zinc intakes [28,29]. 
Although the dietary staple maize, consumed primarily as a liquid porridge, is high in phytate, the 
zinc from the MNP would have substantially lowered the phytate-zinc molar ratio. We did not measure 
intake and absorption from breast milk, but the intake from this source at nine months is likely to be less 
than 0.5 mg per day [30]. Fractional zinc absorption of 0.50 from human milk would be expected [22,31]. 
If this was achievable in this setting, the contribution to physiologic requirements, though modest, could 
be important. 
Markers of intestinal permeability and enteropathy were not obtained in this population, but this is a 
setting and age group in which environmental enteropathy may be common and provide a plausible 
explanation for the poor zinc absorption. Environmental enteropathy is considered to have a negative 
impact on small intestinal function and absorptive capacity [32]. Furthermore, if enteropathy was present 
in these infants, intestinal endogenous zinc losses may also have been relatively high [33] and would 
thus lead to even higher requirements for absorbed zinc. 
The primary determinants of zinc absorption for healthy adults are amount of zinc ingested and dietary 
phytate [34]. For infants and children, the determinants are less clear but may also include gut length or 
age [35]. The effects of inflammation on absorption have not been systematically examined in either 
adults or children. Whether due to enteropathy or other factors, these infants seemed to exhibit an 
impaired homeostatic response. The significant decline in plasma zinc concentrations for all groups 
suggests a failure to improve zinc status despite the intake from MNP. After three months of a generous 
intake, zinc transporters might be expected to be saturated and “down regulated” [34]. In the face of 
potentially relatively high requirements, however, down-regulation would be un-physiologic  
or maladaptive. The placebo group predictably had a higher fractional absorption of zinc, but with  
such low dietary zinc intakes, this response was notably inadequate to compensate to meet zinc 
physiologic requirements. These results in totality emphasize the limits of absorptive mechanisms to 
compensate for adverse conditions, whether due to impaired gut health, immunostimulation, or limited 
dietary intake. 
The EZP sizes were also low relative to the dietary intakes and compared to Denver breastfed infants 
of the same age and with lower dietary zinc intakes [22]. Specifically, despite dietary zinc intakes of the 
MNP groups that were considerably higher than those of Denver infants receiving regular meat or a zinc 
fortified cereal, the EZP sizes of the two MNP groups in the present study were only ~85% of the mean 
EZP sizes for the Denver infants [22]. This, along with the decline in plasma zinc concentrations, further 
supports chronically impaired Zn absorption. Additionally, the mean EZP for the placebo group was 
below our tentative lower cut-off of 3 mg/kg for this age [36].  
The effect of the MNP + Fe on iron status was at best modest, but the small sample size and high 
inflammatory burden greatly complicate the interpretation of the biomarker results. Despite eligibility 
criteria including only mild anemia, and the finding of normal mean ferritin levels at the beginning of 
the intervention at six months, normal iron status cannot be assumed due to the high levels of 
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inflammatory markers, including elevated CRP levels for most subjects. The sTfR values of virtually all 
subjects exceeded the upper limits of normal range at baseline, and were above normal range for most 
subjects at nine months, including for the infants who received the MNP + Fe. In addition to presumed 
negative effect of high phytate diet on iron absorption, the elevated inflammatory state could reasonably 
be expected to also stimulate hepcidin, which would further impair absorption, even in the face of iron 
deficiency [37]. The significant decline in plasma zinc concentrations between six and nine months for 
all groups may also reflect the overall large inflammatory burden, but the small sample size warrants 
cautious interpretation. A recent review of iron supplementation found that administration of iron and 
zinc supplements together resulted in significantly reduced zinc concentrations compared to zinc 
supplements given alone [38]. The iron dose used in the MNP + Fe group is similar to that used in other 
studies of MNP’s, including the study in Tanzania in which iron supplementation in iron-replete subjects 
was associated with more infectious morbidity [1] and in a recent study in which assignment to MNP 
with iron was associated with more frequent bloody diarrhea [39]. Emerging data suggest potential for 
fortificant iron to induce pro-inflammatory changes in the intestine and the microbiota [40–43] but 
evidence for iron-associated systemic inflammation with fortificants is less clear. The lack of effect of 
iron on zinc absorption and the pattern of changes in biomarkers suggests an interaction between these 
two essential trace elements systemically, rather than competition for transport by the enterocyte. 
The notable limitations of this study relate to the smaller than expected sample size for successful 
completion of the demanding zinc metabolic studies. With this limitation, the possibility of failing to 
detect an effect of the iron on zinc absorption due to low statistical power must be considered. However, 
the similarity of the EZP sizes between the two MNP groups, and the significantly higher EZP means 
compared to that of the control group, does not suggest an iron effect on zinc absorption. The strikingly 
high inflammatory burden also greatly increased variability and impacted the ability to detect differences 
in micronutrient status among groups. Although the degree of systemic inflammation suggests 
underlying enteropathy, the lack of markers of intestinal inflammation does not allow confirmation  
of the underlying condition. The strengths of the study were the randomized design; the longitudinal  
follow-up; and the measurements of zinc absorption directly in a population at high risk for both zinc 
and iron deficiencies, for malaria, and for environmental enteropathy. 
5. Conclusions 
No effect of iron on zinc absorption was apparent in this malaria endemic setting when iron was given 
as a component of a MNP. Despite a substantial increase in zinc from the MNP, which brought their 
habitual dietary zinc intakes to double the estimated average requirement for a duration of three months, 
the mean daily absorbed zinc for both MNP groups barely achieved the estimated physiologic 
requirement for this age [26,44,45]. Furthermore, the size of the EZP for both MNP groups was lower 
than observed for breastfed infants in more hygienic settings who had lower habitual zinc intakes [22]. 
All of these observations are consistent with impaired zinc absorption in these breastfed infants at risk 
for zinc deficiency as well as for environmental enteropathy. 
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